[
    [
        {
            "time": "2020-12-17",
            "original_text": "恒瑞医药事件点评：PD-1适应症再扩展 助力公司脱颖而出",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "PD-1",
                    "适应症",
                    "扩展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药事件点评：PD-1适应症再扩展 助力公司脱颖而出",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "连续两天暴跌20%，祸起“1元定增”？荣科科技澄清：系误读 连续下跌",
            "features": {
                "keywords": [
                    "荣科科技",
                    "暴跌",
                    "1元定增",
                    "误读"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "连续两天暴跌20%，祸起“1元定增”？荣科科技澄清：系误读 连续下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "医保谈判第三日场外：投行券商人士急探消息，PD-1市场几大厂商齐聚",
            "features": {
                "keywords": [
                    "医保谈判",
                    "PD-1",
                    "厂商",
                    "齐聚"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医保谈判第三日场外：投行券商人士急探消息，PD-1市场几大厂商齐聚",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "白马股狂飙！白酒第四轮牛市一个茅台碾压整个军工药茅恒瑞新增400亿市值？外资公募共享年末红利！",
            "features": {
                "keywords": [
                    "白马股",
                    "白酒",
                    "恒瑞",
                    "外资",
                    "公募"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白马股狂飙！白酒第四轮牛市一个茅台碾压整个军工药茅恒瑞新增400亿市值？外资公募共享年末红利！",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "恒瑞医药股价创历史新高业内：2021年医药股将迎估值切换硬核资产高估值或成新常态",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "股价",
                    "历史新高",
                    "估值切换"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药股价创历史新高业内：2021年医药股将迎估值切换硬核资产高估值或成新常态",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]